Lemaitre Vascular (LMAT) Total Debt (2020 - 2021)
Lemaitre Vascular's (LMAT) quarterly Total Debt came in at $25.4 million in Q2 2021, down 58.95% year-over-year from $62.0 million in Q2 2020, and down 18.53% quarter-over-quarter from $31.2 million in Q1 2021.
Powered by 
Analysis
Lemaitre Vascular (LMAT) Total Debt (2020 - 2021) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Total Debt for 2 consecutive years, with $25.4 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Total Debt fell 58.95% year-over-year to $25.4 million in Q2 2021; TTM through Jun 2021 was $25.4 million, a 58.95% decrease from a year earlier, with the FY2020 full-year figure at $38.0 million, changed N/A from the prior year.
- Total Debt was $25.4 million for Q2 2021 at Lemaitre Vascular, down from $31.2 million in the prior quarter.
- Over five years, Total Debt peaked at $62.0 million in Q2 2020 and troughed at $25.4 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 28.15 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.94 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 12.62 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 4.15 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 2.14 Bn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 25.45 Mn |
| Mar 31, 2021 | 31.24 Mn |
| Dec 31, 2020 | 38.03 Mn |
| Sep 30, 2020 | 57.23 Mn |
| Jun 30, 2020 | 61.99 Mn |